MedTrace Logo

Canadian Pulmonary Embolism Diagnosis Study (CANPEDS)

NCT00182546 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1126

Last updated 2006-05-03

No results posted yet for this study

Summary

The main objective of the trial is to determine whether D-dimer testing combined with assessment of Pre-Test-Probability (using a standardized clinical model) can be used to markedly simplify the diagnostic process for PE.

It may be safe to omit additional diagnostic testing in selected patients with suspected pulmonary embolism who have a negative D-dimer test

Conditions

  • Suspected Pulmonary Embolism
  • Deep Venous Thrombosis

Interventions

PROCEDURE

Two diagnostic management strategies

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Hamilton Health Sciences Corporation

    lead OTHER

Principal Investigators

  • Clive Kearon, MD, PhD · McMaster University

  • Jeffrey S Ginsberg, MD · McMaster University

  • James Douketis, MD · McMaster University

  • Alexander G Turpie, MB · McMaster University

  • Shannon M Bates, MDCM · McMaster University

  • Mark A Crowther, MD · McMaster University

  • Jeffrey I Weitz, MD · McMaster University

  • Michael Gent, DSc · McMaster University

  • Agnes Y Lee, MD · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-08-31
Completion
2001-01-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00182546 on ClinicalTrials.gov